• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulat

tetano

Editor, Senior Moderator
Vaccine. 2020 Jan 17. pii: S0264-410X(20)30012-8. doi: 10.1016/j.vaccine.2020.01.008. [Epub ahead of print] [h=1]Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay.[/h]
Chromikova V[SUP]1[/SUP], Tan J[SUP]2[/SUP], Aslam S[SUP]1[/SUP], Rajabhathor A[SUP]1[/SUP], Bermudez-Gonzalez M[SUP]1[/SUP], Ayllon J[SUP]1[/SUP], Simon V[SUP]1[/SUP], Garc?a-Sastre A[SUP]3[/SUP], Salaun B[SUP]4[/SUP], Nachbagauer R[SUP]1[/SUP], Krammer F[SUP]5[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The stalk of the influenza virus hemagglutinin (HA) is an attractive target for antibody-based universal influenza virus vaccine development. While antibodies that target this part of the virus can be neutralizing, it has been shown in recent years that Fc receptor-mediated effector functions are of significant importance for the protective effect of anti-stalk antibodies. Several assays to measure Fc-Fc receptor interaction-based effector functions like antibody-dependent cellular cytotoxicity and antibody-dependent cellular phagocytosis exist, but they suffer from limitations such as low throughput and high run-to-run variability. Reporter assays for antibody-dependent cellular cytotoxicity based on reporter cells that express luciferase upon engagement of human FcγRIIIa with the Fc of antigen-bound antibodies have been developed as well. These reporter assays can be used in a higher throughput setting with limited run-to-run assay variability but since they express only one Fc receptor, their biological relevance is unclear. Here we optimized an antibody-dependent cellular cytotoxicity reporter assay to measure the activity of antibodies to the conserved stalk domain of H1 hemagglutinin. The assay was then correlated to a CD107a-based degranulation assay, and a strong and significant correlation could be observed. This data suggests that the FcγRIIIa-based reporter assay is a good substitute for functional assays, especially in settings where larger sample numbers need to be analyzed.
Copyright ? 2020. Published by Elsevier Ltd.


[h=4]KEYWORDS:[/h] ADCC; ADCP; Effector functions; Influenza hemagglutinin; Stalk antibodies

PMID: 31959425 DOI: 10.1016/j.vaccine.2020.01.008
 
Back
Top Bottom